Welcome to another episode in our "State of the Art Series". In this episode, we have the privilege of delving into the world of ARDS with a true pioneer in the field. Join us as we sit down with Professor Danny McAuley to unravel the complexities of ARDS – from its underlying mechanisms to the latest advancements in diagnosis and treatment. Professor McAuley's major interest is Acute Respiratory Distress Syndrome (ARDS). His research strategy in ARDS is to investigate potential novel therapeutic agents in ARDS in vitro, in vivo in human models of ARDS and in phase 2 clinical trials to inform subsequent phase 3 clinical trials. He is currently investigating the role of MSCs, statins and ECCO2R in ARDS.